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ELECTROPHYSIOLOGIC STUDIES
Patients With Supraventricular Tachycardia Presenting With Aborted
Sudden Death : Incidence, Mechanism and Long-Term Follow-Up
YINSHI WANG, MD, MELVIN M . SCHEINMAN- MD . FACC . WALTER W. CHIEN . MD,
TODD J . COHEN, MD, MICHAEL D . LESH, MD. FACC, JERRY C . GRIFFIN, MD, FACC
San Francisco, Colif rnia
A total of 13 (4 .5%) of 290 patients with aborted sudden death had
either documented (7
; 54%) or strong pre.ampdve evidence of
supraventricular tachycardia that deteriorated into ventricular
fibrillation. Six (46%) of the 13 had an accessory conduction
pathway and either atria[ fibrillation IS patients) or paroxysmal
atrioventricular (AV) reentrant tachycardia it patient) that dete-
riorated into ventricular fibrillation . Three patients 00(1k AV node
reentrant tachycardia and four with atria[ fibrillation and en-
hanced AV node conduction presented with supraventricular
arrhythmias that deteriorated into ventricular fibrillation .
Patients were treated with medical, surgical or catheter-
ablative procedures designed to prevent recurrences of supraven-
That ventricular arrhythmias are responsible for the vast
majority of sudden cardiac deaths has been substantiated by
epidemiologic field surveys 11-3), ambulatory eleclrocardio-
graphic (ECG) monitoring (4.5) and electrophysiologic stud-
ies (6-13). Less well documenter' are the incidence of
supraventricular arrhythmias responsible for sudden cardiac
death and the results of long-term follow-up of surviving
patients.
In this report we review our experience with patients with
aborted sudden death who had either documented supraven-
tricular arrhythmia before cardiac arrest or strong presump-
live evidence of the same, as determined by hemodynami-
cally unstable supraventricular arrhythmias induced in the
laboratory- We describe the incidence, mechanism of the
arrhythmias, treatment and long-term follow-up of these
patients .
Methods
Study patients . The study group of 13 patients was de-
rived from 290 consecutive survivors of out-of-hospital
cardiac arrest w ; i , ere referred to the Mofhtt-Long Hospi-
tal between April 1979 and September 1990 for invasive
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tricular arrhythmias. Four patients received an implanted auln-
madc defibrillator, but none had an appropriate device discharge
.
Over a follow-up period of 41 .6 t 33 .6 months, 12 patients are
alive without symptomatic arrhythmias. One patient died because
of severe chronic long disease and heart failure .
Supraventricular tachycardia was the cause of aborted sudden
death in approximately 5% of patients referred for evaluation of
sudden cardiac death, Treatment directed at prevention of so
.
praventricular tachycardia was associated with an excellent prog-
nosis. Current treatment techniques appear to obviate the need
for automatic defibrillator therapy in these patients .
IJ Am Coll Ceediel 1991;18 :1711-9)
cardiac electrophysiologic studies
. All patie,rts had at least
one episode of cardiac arrest with documented ventricular
fibrillation requiring direct current couniershock . An effort
was made to retrieve all ECGs obtained before the cardiac
arrest to discern whether supraventricular arrhythmia was
present before ventricular fibrillation was recorded . All
patients underwent a complete history and physical exami-
nation
. Electrocardiograms and echocardiograms were ob-
tained in all patients and cardiac catheterization and ccro-
nary angiography were performed as clinically indicated
.
Electrophysiologic study
. Administration of all antiar-
rhythmic drugs was discontinued for a period of at least four
to five half-lives for participants of this study . After written,
informed consent was obtained from the patieni. multipolar
electrode catheters were positioned in the right atrium, right
ventricular apes and across the tricuspid valve to record the
His bundle potential . An electrode catheter was inserted into
the coronary sinus as clinically indicated . A total of three to
four surface ECG leads were recorded simultaneously . All
patients underwent overdrive right atria) pacing to a paced
atrial cycle length of 0280 ms and overdrive pacing with
induction of one or two atrial extrastimuli to atria[ refracto-
riness . Ventricular overdrive pacing was initiated from at
least two right ventricular sites and the study included
delivery of a minimum of two premature extrastimuli from
two right ventricular sites at two basic drive cycle lengths
with use of a 3-ms rectangular pulse width at twice diastolic
threshold . All patients in the present study underwent a
ptolacol using triple extrastimuli at two sites
.
n715.109T91i51 .t o
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Table 1. Clinical Characteristics, Therapy and Follow-tip in 13 Patients
In patients without severe coronary artery disease or
cardiomyopathy, the study protocol was repeated after
infusion of isoproterenol, tailored to produce a 20% to 30%
increase in the heart rate . The end point of the study was
either completion of the protocol or induction of a sustained
arrhythmia,
Patient characteristic ::. On the basis of the clinical pre-
sentation or electronhysiologic study, 40 patients were clas-
sified into two groups wi :h respect to the possibility that a
supraventricular arrhythmia was responsible for the cardiac
arrest
. Group 1 consisted of 13 patients who had either or
both documented spontaneous supraventriculartachycardia
that preceded ventricular fibrillation (7 patients) or su-
praventricular tachycardia induced in the laboratory that
required prompt termination because of hemodynamic insta-
bility (10 patients) . Hemodynamic instability was defined as
systolic blood pressure <80 mm Hg associated with severe
symptoms of presyncope, syncope, dyspnea or chest pain .
Group 2 consisted of 27 patients in whom both supraventric-
ular and ventricular tachycardia were induced. Because
supraventricular tachycardia was not and ventricular tachy-
cardia was associated with hemodynamic instability, these
patients were excluded from the study
. Thus, only data from
group I patients are discussed hem .
Follow-up. All patients in group 1 underwent drug ther-
apy monitored by invasive electrophysiologic study and
were discharged either taking drugs that prevented arrhyth-
mia induction or after catheter- or surgical ablative proce-
dures
. All patients were followed up in our cardiac arrhyth-
mia clinic or by their private physician
. Follow-up data were
obtained by interview with the patient or the patient's family
or from the patient's private physician .
'Recorded spontaneous a rrhythmia . AF = atria) fibrillation : AICD = aromatic implantable cardioverter-defibrillator
: AVN mad = atnoventricubr node
modification
: AVRT = onhodromic atrio,entricular reentrant tachycardia : CABG = coronary artery bypass grafting : CAD =coronary artery disease; CMP =
idiopathic cardiamyopelby; COPD = chronic obstructive pulmonary disease : EF = ejection fraction : F = female
: Fill = follow-up; IHSS = hypeoraphic
eardiomyopalhy
: M = male : Pt = patient : VF = ventricular fibrillation .
Results
Study group . A total of 13 patients (4 .5%) amoa2 the 290
patients with aborted sudden cardiac death had documented
or strong presumptive evidence that episodes of supraven-
tricular tachycardia triggered malignant ventricular arrhyth-
mias . Spontaneous supraventricular tachycardia that deteri-
orated into ventricular fibrillation was documented in seven
patients from the ECGs recorded by paramedics (one pa-
tient) or at emergency facilities (six patients)
.
Wolff-Parkinson-White syndrome . Six (46%) of the 13
patients (Cases I to 6) had orthodromic atrioventricular (AV)
reentrant tachycardia (Table 1)
. The mean age of this group
was 29 .7 ± 13.5 years and the mean duration of
symptomatic
palpitation before cardiac arrest was 7 ± 6 .1 years . Only one
patient (Case 6) had cardiac arrest as the first manifestation
of the Wolff-Parkinson-White syndrome . Hemodynamically
unstable atrial fibrillation occurring spontaneously (Fig
. 1) or
induced in the catheterization laboratory was present in five
patients . Five of the six patients had no evidence
of organic
cardiac disease (all had normal findings on cardiac catheter-
ization or echocardiographic studies) and one had nonob-
structive hypertrophic cardiomyopathy . The latter patient
(Case 5) had documented rapid orthodromic AV reciprocat-
ing tachycardia that deteriorated into ventricular fibrillation .
In the six patients with the Wolff-Parkinson-White syn-
drome, the mean accessory pathway anterograde effective
refractory period was <242 ± 32 .7 ms . The determination of
accessory pathway refractoriness was limited by atria) re-
fractoriness in three patients (Cases 1, 2 and 4). The mean
shortest pre-excited RR interval during induced atria) fibril-
lation was 207 ± 24 .9 ms (range 180 to 245) (Table 2)
. The
mean pre-excited RR interval during atria) fibrillation was
256 ± 37 ms. Atria) fibrillation could not be induced in one
PI
No
.
Age Iyrtl
Gender
Sympiam
Duration Cardiac
Diagnosis Arrhythmia'
EF
lOt
Fill
Therapy (me)
53'F Normal AF-VF 55 Fl-in'e 2
I6'M Normal VF 69 Surgery 81
36P
Normal .AF-VF 73 Catheter ablation 52
33'F Normal AF-VF 63 Surgery I8
2"M HISS .AVRT-VF 88 Surgery. AICD 27
191M Normal
VF 55 Surgery 132
SIIF 4 CAD VF 75 Verapamil 19
8 371r No Normal
VF 55 AVNmad .AICD 27
9 31iF No Normal VF 55 Propranolet 40
10 691F No CMP VF 30 Catheter ablation. AICD 34
II
611F
No CMP AF-VF 55 Catheter ablation. verapamil 52
12
69,F
I CAD
AF-VF 40 CABG. AICD 26
13 65iM 2
CMP. COPE,
AF-VF 25
Catheter ablation 36
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Figure L Patient 3 . Baseline I'--
lead electrocardiog, . m showing
pre-excitation over a posteroseptal
accessory bypass u-aci . This patient
presented with canal fibrillation
with rapid ventricular response
(lead II) that deteriorated into ven-
tricular fibrillation . F, L . R = leads
aVF, aVL and aVR, respectively .
t
patient (Case 5) . but during the study, this patient had
hemodynamically unstable rapid paroxysmal supraventricu-
lar tachycardia that required emergency direct current
shocks for termination. During the same period, a total of
304 patients with the Wolff-Parkinson-White syndrome un-
derwent electrophysiologic study in our laboratory and 8
(3%) presented with aborted sudden death . Two of the eight
patients with Wolff-Parkinson-White syndrome and sudden
cardiac death were excluded from this study because the
sudden cardiac death was thought to be related to malignant
ventricular arrhythmia in older patients with severe coro-
nary artery disease .
AV node reentrant tachycardia . Three patients (Cases 7
to 9) with AV node reentrant tachycardia were included in
the present study: their mean age was 46 .3 ± 13 .6 years
(Table I). One (Case 7) had a 50% lesion of the right
coronary artery. This patient had a 4-year history of recur-
rent palpitation and chest pain and right coronary artery
spasm was induced after ergonovine administration. Induced
typical AV node reentrant tachycardia was associated with
marked ST depression in the inferior ECG leads and a
pattern of symptoms (palpitation and chest pain) identical to
WANG ET AL
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that of the patient's clinical episodes . The two other patients
with AV node reentrant tachycardia had no evidence of
coronary artery or cardiac disease . Aborted sudden cardiac
death was the initial presentation for two of the three
patients .
Induced AV node reentrant tachycardia in all patients
was associated with severe hypotension that necessitated
prompt termination of the arrhythmia by cardiac pacing (Fig .
2)
. All patients had the typical form of AV node reentrant
tachycardia and the mean tachycardia cycle length was
'_93 .3 - 20.8 ms (range 270 to 310) . The mean AV node
effective refractory period was 260
.
8.2 ms (range 250
to 2701 (Table 2) . During this same interval, a total of 116
patients had AV node reentrant tachycardia diagnosed by
electrophysiologic study in our laboratory and 12 presented
with aborted sudden cardiac death . In 5 of the 12 patients,
ventricular tachycardia or fibrillation was readily inducible
and 4 other patients had no significant hemodynamic com-
promise
: hence, these 9 patients were excluded from the
study . For purposes of this study, 3 (3%) of the 116 patients
with AV node reentrant tachycardia were thought to have
sudden cardiac death due to this arrhythmia .
Table 2. Electrophysiologic Data From Nine Patients With .Atrioventricular IAV) Reentrant In = 6)
or AV Node Reentrant in = 3) Tachvcardia
	O
bserved after soprolercnoi. Observed after ptncuinamide : !Atrioveelocular node IAVNI effective refractory
period IERPI not determined because of vlnual incessant tachycardia
. AFRR = shooed pre-excised RR interval
during atnal fihnllation'. AP =accessory pathway. AVNRT - atriuvenlricular node reentrant mchyordia
; LL - left
lateral
path.
LP = left posterior Pathway. PS = poserior
sepal pathway ; SVLCL = scprovenirai lar
tachycardia cycle length, other abbreviations as in Tahle I .
Pt
No .
Induced
Arrhythmia
SVT-CL
loll
AFRR
Imsl
AP. ERP
Inil
AP
Location
AVN-CRP
/ms)
I AVRTIAF
300 210' "_30 LP and PS
AVRTIAF 260 190' 5200 LL
AVRTIAF 290 180 330 PS
AVRTIAF rso _.-
52'0 LL
AVRT
290 Concealed LP
AF 210 2 511 LP
AVNRT 310
790
AVNRT 77D
2m
AVNRT 300
1714
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Patients with enhanced AV node conduction (atria) fibrih
lation/flutter) . Four (31%) of the 13 study patients (Cases 10
to 13) had atria) fibrillation associated with rapid ventricular
responses (Tables I and 3) . Documented atria) fibrillation or
flutter preceded ventricular fibrillation in three patients and
was induced in one . These four patients had a mean age of
65 .8 ± 3 .6 years and all had structural heart disease . Patient
10 had severe hypertensive cardiomyopathy with a prior
history of congestive heart failure and an ejection fraction of
Mo. Patient 12 had a history of prior myocardial infarction ;
coronary angiography showed complete occlusion of the left
anterior descending artery and a critical lesion in the right
coronary artery . She was treated with flecainide far control
of atrial fibrillation and premature ventricular complexes and
was referred to our hospital after she had a cardiac arrest
during an exercise treadmill test (Fig . 3). Patient 13 had
severe pulmonary disease. chronic alcoholism and a history
of atrial flutter with ventricular response of 250 beats/min
(Fig. 4) .
All four patients showed enhanced AV node conduction .
JACC Val . IS.
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Figure 2 . Patient 8. Simultaneous recordings of
surface electrocardiographic leads V„ l, Il and
aVF together with high right atrial (HRA) and His
bundle electrogram (HBE) and coronary sinus
f
	
a Ian ICS) and arterial pressure (AP) recordings during
induced typical atrioventricular node reentrant
tachycardia
. The tachycardia produced hemody-
namic collapse and required emergency termina-
tion.
The mean shortest RR interval during atrial fibrillation was
223 ± 25 ms . The mean AV node effective refractory period
was <210 ± 18.3 ms and the mean AV node block cycle
length was 241 .3'- 31 .2 ms . For Patient 10, the baseline AH
interval was 70 ms, but during right atrial overdrive pacing,
the His deflection merged with the end of the septa) atria)
electrogram (Fig. 5A) . The maximal AH interval occurred
during I :1 conduction at a paced cycle length at 250 ms (Fig .
5B) . These findings were consistent with an atsio-Hisian
bypass tract. During induced atrial fibrillation, the shortest
RR interval was 220 ms and the patient developed chest pain
associated with marked anterior ST segment elevation and a
reduction of systemic pressure to 60 mm Hg .
Patient I I had atrial fibrillation that resulted in ventricular
fibrillation (Fig . 6A) and findings consistent with rapid AV
node conduction and an atriofascicular bypass tract . Rapid
overdrive pacing was associated with shortening of the HV
interval and evidence of minor ventricular pre-excitation
(Fig. 6B). The AH interval was 45 ms and increased by only
30 ms with atria) overdrive pacing at a cycle length of
Table 3 . Electrophysiologic Findings in Four Patients With Enhanced Atrioventricular Conduction and Atial Flutter
'Atrio-His pathway; tAtriofascicular pathwa)aaaer isuprumannl administration ; SAH = maximal changes in AH interval at maximal right atria) overdrive
pacing rates associated with 1 :1 atdoventdcular conduction . AVN .BCL = AV mate bleak cycle length ; other abbreviations as in Tables I and 2 .
P1
No.
Induced
Arrhythmia
AF/RR
Ims1
AVN-ERP
Ass)
AVN-OCL
(ms)
AH CAH
(mst Ian)
10
AF' 250'220!
<220
<250 70 30
11
AF ,
2ttTtOt <190 200 45 30
Ir AF 250 <230 240 so 60
13 AF 220 <200 <275 60 -
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Figure 3. Patient 12 Electrocardio
graphic (ECG) strips taken from a
treadmill exercise test . Surface ECG
leads 1, 11 and Ill are shown during
curious stages ora modified Bruce pro-
tocol . Sinus rhythm (first column( is
replaced by atrial fibrillation after
I min 45 s of exercise (second column(,
at which time exercise was terminated .
Approximately I min into recovery
(third column( . a wide irregular rapid
tachycardia emerged, then deterio-
rated into ventricular fibrillation
(fourth column) requiring emergency
tmnsthoeacic shocks. HR = heart rate .
r-:-r•T
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250 ms . Patient 12 also had evidence of enhanced .AV node
conduction and induced atria) tachycardia was associated
with a rate of 250 beats/min ; the shortest RR interval during
atrial fibrillation was 250 ms . Patient 13 had atrial flutter with
1 :1 AV conduction and a ventricular rue up to 250 bears/
min ; subsequent atrial fibrillation degenerated into ventricu-
lar fibrillation (Fig. 4)
.
Among the entire group of 290 patients with aborted
sudden death, persistent atrial fibrillation was induced in an
additional 13 patients, 4 of whom also had inducible sus-
Figure 4. Patient 13 . Representative sei,'ice
electrocardiographic recordings showing
atrial flutter with 2 :1 atrioventricnlar 1.4V1
.-lion
(upper right panel) . Atria] flutter
wnh 1 :1 AV conduction is documenled in the
middle two strips. The bottom strip shows
atrial fibrillation with rapid ventricular re-
sponse that preceded ventricular fibrillation
(recordings are not continuous( .
s5ANG ET 11 -
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rained ventricular arrhythmias and were excluded from
study. Nine patients had inducible sustained atrial fibrilla-
tion . but without demonstrated hemodynamic instability
during supraventricular tachycardia. Enhanced AV node
function was found in two of these nine patients . These two
patients were excluded from the study because induced
atrial fibrillation did not mimic the spontaneous clinical
event . Another two of these nine patients were excluded
because the possibility of drug-related proarrhythmia could
not be eliminated . Atria) tachycardia could be consistently
1716
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induced in four patients ; two of the four had inducible
ventricular arrhythmias and none of the remaining patients
showed hemodynamic instability during atria) tachycardia
.
Treatment and follow-up. The 13 study patients were
followed up for a mean of 41 .6 t 33
.6 months (range 2 to
132)
. Patients I to 12 are alive and have had no symptomatic
arrhythmias or syncope after appropriate treatment of their
tachycardia
. Patient 13 died of severe chronic pulmonary
disease and progressive heart failure . Five of the six patients
JACC VA . It . No. 7
December I991 :"I T,
Figure 5. Patient 10 . A
. High right
atria) overdrive pacing at a cycle
length of 500 ms (S, -St reveals
fusion of the His deflection into the
low septa) atria) electrogram . A
programmed atria[ extrastimulus
(S,) applied near the atrioventricu-
lar node (AV) refractory period
produces maximal lengthening of
the AV node conduction time (AH),
which is similar to that inscribed
after pacing
. The true baseline AH
interval (not shown) for this patient
was 70 ms . B, Right atriat overdrive
(ROD) pacing at a cycle length of
250 ms results in only minimal pro-
longation of the AH interval and is
associated with a profound de-
crease in arterial pressure (AP)
.
Similar hemodynamic findings were
produced during atrial fibrillation.
Abbreviations as in Figure 2
.
with the Wolff-Parkinson-White syndrome underwent cath-
eter or surgical ablation of the accessory pathway and one
(Patient I) received drug therapy . Patient 5, with the Wolff-
Parkinson-White syndrome and hypertrophic cardiomyopa-
thy, underwent attempted surgical resection of the bypass
tract and insertion of an imp!antable cardioverter-
defibrillator because his basic disease process placed him at
risk for ventricular arrhythmias
. Recurrent device dis-
charges were documented to be due to return of AV reen-
JACC Vol . 18, Na . 7
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Figure 6 . Patient II . A, Rhythm
strip showing atrial fibrillation with
rapid ventricular response that later
developed into ventricular fibrilla-
tion. The strips are not continuous .
B, Right atria] overdrive pacing
(ROD) produces a pattern of inter-
mittent pre-excitation . The first
three complexes show merging of
the His deflection with the sepral
ventricular electrogr m . The fourth
and sixth complexes are conducted
over the atriovcnuicular node-His
axis and are conducted with a short
AH interval (50 ms) and a normal
HV interval . Note the minor
changes in the surface QRS com-
plex (especially in lead 11) between
pre-excited and normally con-
ducted complexes . We interpret the
decreased AH and HV intervals
during pre-excited complexes to he
due to anterograde conduction over
a right atriofascicular bypass tract
with retrograde activation of the
His bundle . Note the consistent
change in His bundle contour com-
paring normally conducted (beats
four and six) with pre-excited c om-
plexes. CL
= cycle length: other
abbreviations as in Figure 2 .
tram tachycardia and he was subsequently treated success-
fully with catheter ablation of the posterior free wall
pathway .
Twc of the three patients who presented with AV node
reentrant tachycardia before availability of the implantable
cardioverter-defibrillator (Patients 7 and 9) were successfully
treated with drug therapy . Patient 8 was initially treated with
flecainide and an automatic defibrillator. She had recurrent
defibrillator shocks as a result of recurrence of her AV node
reentrant tachycardia (Fig. 7) and insisted on removal of the
unit . She subsequently underwent a catheter AV node
modification procedure and remains asymptomatic without
drug therapy for approximately I year .
Three (Patients 10, 11, 13) of th^ four patients with atrial
fibrillation and enhanced AV node conduction did nor re-
spond to multiple trials of an.-arrhythmic agents including
Figure 7. Patient 8. Electrocardiographic strips in a patient with
known alrioventricular node reentrant tachycardia IAVNRTI show-
ing suprventrieular tachycardia initiating a discharge of the auto-
matic cardioverlerdefibrillator.
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beta-ndrenergic Mockers and calcium channel blockers and
were treated with catheter ablation of the AV junction and
pacemaker insertion . The fourth patient (Patient 12) under-
went coronary bypass surgery and insertion of an implant-
able cardiovetter-defibrillator and was treated with quiridine
and nadolol ICorgard). After a follow-up period of 26
months, she has not received a single automatic internal
cardiac defibrillator discharge .
Discussion
Incidence
and Mechanism
Se -oral case reports have documented that patients with
supra,nlricular arrhythmias may present with ventricular
fibrilla' •on . However, there is little information concerning
the incidence and follow-up of these patients . In a large
cohort of patients accumulated over !0 years, we found that
the minimal incidence of this association was 4 .5%.
Wolff-Parkinson-White syndrome. Although published
data (14-16) stress the relation between atrial fibrillation in
patients with the Woltf Parkinson-White syndrome with a
short accessory pathway refractory period and sudden
death, we found this mechanism in <50%0 (n = 5) of our
13 patients. In general, our observations confirm the conclu-
sion of a much larger series of patients with Wolff-
Carkinson-While syndrome and sudden death reported by
Klein et al . (14) . All except one of our patients had repeated
1718 WANG El AL.
SUPRAVENTRICULAR TACHYCARDIA AND SUDDEN DEATH
episodes of arrhythmia, and alt had a very short accessory
pathway refractory period . One of our patients had dual
accessory pathways . Two additional patients with the Wolff-
Parkinson-While syndrome and aborted sudden death were
excluded because the mechanism of sudden death was most
likely related to ventricular arrhythmias, an association
previously reported by Lloyd et al . (171.
Atrioventricular (AV) node reentrant tachycardiac . We
report the largest series of patients with AV node reentrant
tachycardia who Present with aborted sudden death . Pa-
tients in this subgroup were older than those with the
Wolff-Parkinson-While syndrome, but only one had associ-
ated coronary artery disease, In this patient, coronary spasm
was readily inducible with ergonovine and induction of the
tachycardia preduced chest pain and ST changes identical to
those of her clinical episode and to those provoked by
ergonovine . We are not aware of prior reports of coronary
artery spasm initiated by tachycardia . Atrioventricular node
reentrant tachycardia was previously reported by Hays et al .
(18) as a cause of sudden death in I of 100 patients with
aborted sudden death. Bcnditt el al . (19) also reported a
patient with ventricular fibrillation who had AV node reen-
trant lachycardia and ventricular tachycardia. Although the
diagnosis is presumptive in our patients with AV node
reentrant tachycardia . therapy directed at tachycardia con-
trol prevented recurrence of aborted sudden death .
Atria) fibrillation/flutter with rapid AV node conduction .
In four patients atrial fibrillation accompanied by a very
rapid ventricular response was associated with aborted
sudden death
. An atrio-Hisian pathway was found in one
patient and an atriofascicular pathway in another. Three of
these four patients had significant organic cardiac disease
and were older than those with the Wolff-Parkinson-White
syndrome . In one patient (Case 12), the conversion of atrial
fibrillation to ventricular fibrillation occurred during an ex-
ercise stress test while the patient was receiving flecainide
therapy . Similar cases have been reported by others (20,21) .
Prior reports have documented the association of rapid AV
node conduction and sudden death
. In 1952, Lown et al . (22)
reported the association of a short PR interval and narrow
QRS complexes with recurrent atrial fibrillation or atrial
flutter, and two of their patients died suddenly .
We found only 10 cases in English language studies
(22-25) documenting that atrial fibrillation in the absence of
the Wolff-Parkinson-White syndrome could lead to sudden
death
. In some reports . atrio-Hisian pathways or enhanced
AV node conduction was documented
. The presence of an
atriofascicular pathway was recently well documented by
Koo et al . (26). In their report, serial overdrive pacing
resulted in progressive fusion of the His deflection into the
QRS complex, but without a change in QRS configuration .
In our Patient 11, a similar finding occurred, except that
minor hanges in the QRS complex were identified on the
surface ECG recording .
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Lirnilarrorts
Several important limitations of this study should be
emphasized . First, clear spontaneous documentation of the
supraventricular arrhythmia that deteriorated into ventricu-
far fibrillation was available iu only 7 of the 13 patients . The
relation between the two arrhythmias in the remaining
patients remains inferential . Nevertheless, the inference is
plausible for two reasons : I) induction of supraventricular
tachycardia precipitated a hemodynamically unstable situa-
tion ; and 2) treatment directed at the supraventricular tachy-
cardia appears to have been associated with long-term
successful arrhythmia control . More likely, the incidence
reported in our study represented a minimal incidence of
supraventricular tachycardia as a cause of ventricular fibril-
lation because aggressive pacing techniques for induction of
atria) fibrillation were not routinely applied and isoprotere-
nol provocation was not used in all patients . Although
isoproterenol was used in all patients without coronary
artery disease and without inducible ventricular tachycardia,
it was not applied in those with significant coronary artery
disease or cardiemyopathy . A significant number of addi-
tional patients had the substrate for supraventricular ar-
rhythmias,including inducible AV node reentrant tachycar-
dia, atrial tachycardia and enhanced AV node conduction,
but our study did not conclusively prove that supraventric-
ular tachycardia led to hemodynamic collapse or ventricular
fibrillation .
Other limitations include inclusion of patients with hyper-
trophic or dilated cardiomyopathy in whom inducibility of
ventricular arrhythmias may be variable . In addition, hemo-
dynamic instability during tachycardia may have resulted
from the infusion of isoproterenol . One of the important
arguments supporting a link between supraventricular tachy-
cardia and sudden cardiac death is the patient response to
therapy for tachycardia . This conclusion has to be evaluated
in light of the relatively small sample size and the expected
superior prognosis for these patients .
One patient (Case 9) with AV node reentry experienced
hemodynamic collapse with a tachycardia cycle length of
300 ms in the absence of obvious organic cardiac disease .
The reason for this response is uncertain but may be related
to reflex effects on systemic resistance due to atria] contrac-
tion against a closed Initial (and tricuspid) valve . Recurrent
cardiac arrest in young persons is much less frequent in
those without than in those with obvious organic cardiac
disease
. Thus, it is difficult to assume that the excellent
prognosis was, in .sc . related to specific treatment of the
AV node reentrant tachycardia in these patients with no
structural heart disease .
Clinical bnplicurions
Our observations suggest that patients with aborted sudden
death should be carefully screened for possible supraventric-
ular tachycardia, which may have triggered the cardiac
arrest. Such an evaluation should include judicious use of
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isoproterenol and induction of atrial fibrillation, particularly
in patients who do not have inducible ventricular
arrhyth-
mia,
Patients with the Wolff-Parkinson-White syndrome tend
to be younger and to have no associated cardiac disease . Our
patients with AV node reentrant tachycardia or atrial fibril-
lation and enhanced AV node conduction were older and had
a higher incidence of associated cardiac disease
. The latter
consideration is important because arrhythmias that may be
well tolerated in the absence of cardiac disease may prove to
be lethal when cardiac disease supervenes,
The implantable cardioverter-defibrillator. This device
was not available during initial presentation for the majority
of our patients. Because the precise documentation linking
supraventricular tachycardia with ventricular fibrillation will
be absent it . many clinical instances, defibrillator insertion
may be selected (as in four patients in our series) as a
fail-safe p rocedure. i t should be emphasized that the pres-
ence of a drug-refractory supraventricular arrhythmia
greatly complicates the use of the implantable cardioverter-
defibrillator . For example, if shocks are triggered by su-
pt'avenViculat' tachycardia, it is likely that the defibrillator
will not be effective for this arrhythmia and may conceivably
induce ventricular fibrillation . Of the four patients who
underwent device insertion, one insisted that the unit be
removed after she received multiple discharges documented
to be due to supraventricular tachycardia ; the other three
patients remain asymptomatic on drug therapy and have not
received defibrillator discharges. Our observations suggest
that appropriate and aggressive management of supra-
ventricular tachycardia may make the insertion of an im-
plantable cardioverter-defibrillator unnecessary for these
patients .
The technical work of Eric 1'ee and the secretarial wark of Carol loaba and
Felicitas Militias are grmeNlly acknowledged .
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